Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 2/20 | 0.41 |
| ▸ | ALPI | P09923 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | XIAP | P98170 | 1/20 | 0.41 |
| ▸ | GRIA2 | P42262 | 4/20 | 0.39 |
| ▸ | GRIA1 | P42261 | 3/20 | 0.39 |
| ▸ | GRIA3 | P42263 | 3/20 | 0.39 |
| ▸ | GRIA4 | P48058 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Histidine SCHEMBL30038780 | 0.98 | SLC7A5 (0.46) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| D-Histidine SCHEMBL28977992 | 0.98 | SLC7A5 (0.46) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL123617 | 0.98 | SLC7A5 (0.46) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL6005504 | 0.98 | SLC7A5 (0.46) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL1032558 | 0.98 | SLC7A5 (0.46) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL32678352 | 0.97 | SLC7A5 (0.45) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL31754612 | 0.97 | SLC7A5 (0.45) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL2782310 | 0.97 | SLC7A5 (0.45) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL2782319 | 0.97 | SLC7A5 (0.45) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL32678354 | 0.97 | SLC7A5 (0.45) | SLC7A5CYP3A4CYP1A2PKMALPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104886-A1 | METHOD FOR EXTRACTING LOW-MOLECULAR WEIGHT COLLAGEN USING POLLACK SKIN, LOW-MOLECULAR WEIGHT COLLAGEN, AND COSMETIC COMPOSITION COMPRISING SAME WITH SKIN REGENERATION EFFICACY | 유엔케이코리아 주식회사 | 2026-05-21 | — | — | WO | disclosed |
| US-12350352-B2 | Composition for surface modification | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2025-07-08 | — | — | US | disclosed |
| EP-4464307-A1 | COSMETIC COMPOSITION AND METHODS OF MAKING THE SAME | MPLUS COSMETICS S.R.L. (IT) | 2024-11-20 | — | — | EP | disclosed |
| US-20240374498-A1 | COSMETIC COMPOSITION AND METHODS OF MAKING THE SAME | MPLUS COSMETICS S.R.L. (IT) | 2024-11-14 | — | — | US | disclosed |
| EP-3342395-B1 | COMPOSITION FOR HAIR SURFACE MODIFICATION | LG HOUSEHOLD & HEALTH CARE LTD (KR) | 2024-08-07 | — | — | EP | disclosed |
| EP-4406617-A2 | COMPOSITION FOR SURFACE MODIFICATION | LG Household & Health Care Ltd. (KR) | 2024-07-31 | — | — | EP | disclosed |
| CN-116490598-A | Detergent compositions with enhanced efficacy delivery of substances | 株式会社LG生活健康 | 2023-07-25 | — | — | CN | disclosed |
| US-11612552-B2 | Composition for surface modification | LG HOUSEHOLD & HEALTH CARE LTD. | 2023-03-28 | — | — | US | disclosed |
| US-20230088314-A1 | Composition For Surface Modification | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2023-03-23 | — | — | US | disclosed |
| WO-2022114681-A1 | CLEANSER COMPOSITION WITH ENHANCED ACTIVE SUBSTANCE DELIVERY | 주식회사 엘지생활건강 | 2022-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12350352-B2 | Composition for surface modification | CUTA, PTMS, DNMT1 | SLC7A5 4300/4885CYP3A4 597/4885CYP1A2 676/4885 |
| US-20230088314-A1 | Composition For Surface Modification | CUTA, PTMS, DNMT1 | SLC7A5 4300/4885CYP3A4 597/4885CYP1A2 676/4885 |
| US-11612552-B2 | Composition for surface modification | CUTA, PTMS, DNMT1 | SLC7A5 4300/4885CYP3A4 597/4885CYP1A2 676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.